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WI ABSTRACT 
The present invention relates to a multicellular, three- 
dimensional, living mammalian tissue. The tissue is pro- 
duced by a co-culture process wherein two distinct 
types of mammalian cells are co-cultured in a rotating 
bioreactor which is completely filled with culture 
media and cell attachment substrates. As the size of the 
tissue assemblies formed on the attachment substrates 
changes, the rotation of the bioreactor is adjusted ac- 
cordingly. 
1992) pp. 47-60. 
22 Claims, No Drawings 
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MULTI-CELLULAR, THREE-DIMENSIONAL 
LIVING MAMMALIAN TISSUE 
ORIGIN OF T H E  INVENTION 
The invention described herein was made in the per- 
formance of work under NASA contract and is subject 
to  provisions of Section 305 of the National Aeronautics 
and Space Act of 1958, Public Law 85-568 (72 Stat. 435; 
42 U.S.C. 2457). 
RELATED APPLICATIONS 
This application is a continuation of U.S. patent appli- 
cations Ser. No. 07/317,931 filed, Mar. 2, 1989, now 
U.S. Pat. No. 5,153,132, which is a continuation-in-part 
of U.S. Ser. No. 07/213,558, filed Jun. 30, 1988, now 
U.S. Pat. No. 5,026,650, which is a continuation-in-part 
of U.S. Ser. No. 07/213,559, filed Jun. 30, 1988, now 
U.S. Pat. No. 4,988,623, all of which are specifically 
incorporated as fi fully set forth herein. 
FIELD OF T H E  INVENTION 
The process of the present invention relates to a 3- 
dimensional coculture process. By the process of the 
present invention a variety of cells may be cocultured to 
produce tissue which has 3-dimensionality and has some 
of the characteristics of in vivo tissue. The process 
provides enhanced 3-dimensional tissue which creates a 
multicellular organoid differentiation model. 
BACKGROUND OF T H E  INVENTION 
Cell culture processes have been developed for the 
growth of single cell bacteria, yeast and molds which 
are resistant to environmental stresses or are encased 
with a tough cell wall. Mammalian cell culture, how- 
ever, is much more complex because such cells are more 
delicate and have more complex nutrient and other 
environmental requirements in order to maintain viabil- 
ity and cell growth. Large scale culture of bacterial 
type cells is highly developed and such culture pro- 
cesses are less demanding and are not as difficult to 
cultivate as mammalian cells. These techniques are 
highly empirical and a firm theoretical basis is not de- 
veloped. Bacterial cells can be grown in large volumes 
of liquid medium and can be vigorously agitated with- 
out any significant damage. Mammalian cells, on the 
other hand, cannot withstand excessive turbulent action 
without damage to the cells and must be provided with 
a complex nutrient medium to support growth. 
In addition. mammalian cells have other sDecial re- 
placed within cylinders which are rotated about a hori- quirements, in particular most animal cells must attach themselves to  some substrate surface to remain viable zontal axis. and to duplicate. On a small scale, mammalian cells A paper entitled, “The Large-Scale Cultivation of have been grown in containers with small microwells to 
provide surface anchors for the cells. However, cell 55 Cells”* by Joseph Feder and R. 
culture processes for mammalian cells in such mi- Tolbert, was published in the Scientific American, Jan- 
crowell containers generally d o  not provide sufficient uary 1983p vOL 248* No. 1. pps. 36-43. In this paper, 
surface area to grow mammalian cells on a sufficiently agitation of the cells is described as required to keep the 
large scale basis for many commercial or research appli- cells suspended in the medium and describes a turbine 
cations. T o  provide greater surface areas, microcarrier 60 agitator, a marine Propeller agitator, and a vibro mixer 
beads have been developed for providing increased for mixing. The paper also describes a perfusion reactor 
surface areas for the cultured cells to attach. Microcar- in which an agitation is provided by four Slowly rotat- 
rier beads with attached cultured cells require agitation ing flexible sheets of monofilament nylon which are 
in a conventional bio-reactor vessel to provide suspen- rotated about a vertical axis while the medium in the 
sion of the cells, distribution of fresh nutrients, and 65 main vessel is continuously pumped to the satellite filter 
removal of metabolic waste products. To obtain agita- vessel. The filter retains the cells which are pumped 
tion, such bio-reactor vessels have used internal propel- along with the remainder medium back into the vessel 
lers or movable mechanical agitation devices which are for further proliferation. 
motor driven so that the moving parts within a vessel 
cause agitation in the fluid medium for the suspension of 
the microcarrier beads and attached cells. Agitation of 
mammalian cells, however, subjects them to high de- 
5 grees of shear stress which can damage the cells and 
limits ordered assembly of these cells according to cell 
derived energy. These shear stresses arise when the 
fluid media has significant relative motion with respect 
to  vessel walls, impellers, or other vessel components. 
lo Cells may also be damaged in bio-reactor vessels with 
internal moving parts if the cells or beads with cells 
attached collide with one another or vessel compo- 
nents. 
In addition to the drawbacks of cell damage, bio- 
l 5  reactors and other methods of culturing mammalian 
cells are also very limited in their ability to provide 
conditions which allow cells to assemble into tissues 
which simulate the spatial three-dimensional form of 
2o actual tissues in the intact organism. Conventional tissue 
culture processes limit, for similar reasons, the capacity 
for cultured tissues to express a highly functionally 
specialized or differentiated state considered crucial for 
mammalian cell differentiation and secretion of special- 
25 ized biologically active molecules of research and phar- 
maceutical interest. Unlike microorganisms, the cells of 
higher organisms such as mammals form themselves 
into high order multicellular tissues. Although the exact 
mechanisms of this self-assembly are not known, in the 
30 cases that have been studied thus far, development of 
cells into tissues has been found to be dependent on 
orientation of the cells with respect to each other (the 
same or different type of cell) or other anchorage sub- 
strate and/or the presence or absence of certain sub- 
35 stances (factors) such as hormones, autocrines, or para- 
crines. In summary, no conventional culture process is 
capable of simultaneously achieving sufficiently low 
shear stress, sufficient 3-dimensional spatial freedom, 
and sufficiently long periods for critical cell interactions 
40 (with each other or substrates) to allow excellent mod- 
eling of in vivo tissue structure. 
Paper entitled: “The Clinostat-A Tool For Analyz- 
ing The Influence of Acceleration On Solid-Liquid 
Systems” by W. Brieoleb, was published by the pro- 
45 ceedings of a workshop on Space biology, Cologne 
Germany, on Mar. 11, 1983, (ESASP-206, May 1983). 
In this paper, clinostat principles are described and 
analyzed relative to  gravity effects. Some clinostat ex- 
periments are described including experiments where 
50 monocellular suspended organisms (protozoans) are 
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A paper entitled, “Gravisensitivity of the Acellular, 
Slime, Mold, Physarum, Polycephalum Demonstrated 
on the Fast Rotating Clinostat”, by Ingrid Block and 
Wolfgang Brigley, published in the European Journal 
of Cell Biology 41, pps. 44-50, 1986 describes rotation 
of a culture vessel about a horizontal axis for the simula- 
tion of weightlessness. 
Paper entitled “Cell and Environment Interactions in 
Tumor Microregions: The Multicell Spheroid Model”, 
by Robert M. Sutherland, Science 240: 177-184, (1988) 
discloses the use of multicell spheroids, without attach- 
ment substrates, of tumor cells to study cell and envi- 
ronment interactions in tumors. Conventional culture 
processes are utilized to produce limited size and viabil- 
ity tumor cell aggregates. 
Cell cultures from various bio-reactors, including a 
slow turning lateral vessel (STLV) designed for batch 
culture of cells were presented at a poster session at the 
First Canadian Workshop on R 8c D Opportunities on 
Board the Space Station, National Research Council 
Canada, May 6-8, 1987, Ottawa, Canada, and published 
in the Proceedings “Spacebound ’87”, as a paper enti- 
tled “Growth and Maintenance of Anchorage Depen- 
dent Cells in Zero Headspace Bioreactor Systems De- 
signed For Microgravity”, by Lewis et al. 
Paper entitled “Culturing Hepatocyte and other Dif- 
ferentiated Cells” by Lola M. Reid and Douglas M. 
Jefferson, Hepatology Vol. 4 No. 3 pp 548-560 (1984) 
discloses limited techniques for the coculturing of hepa- 
tocytes and other differentiated cells. The techniques 
disclosed in the paper make use of floating collagen 
gels, which are severely restricted in their 3-dimen- 
sional aspect and cocultured with fibroblasts moder- 
ately to cocultivate differentiated layers of tissue. These 
techniques do not permit macroscopic inspection of the 
tissue being cultured as a result of the limited size of the 
resulting tissue. 
Paper entitled “Tissue Culture Model of Adenoma 
Invasion” by Eileen A. Friedman Seminars in Surgical 
Oncology 3:171-173 (1987) discloses a model for use of 
2-Oncology dimensional cocultivation to study the de- 
structive capability of colon carcinoma cells when ex- 
posed to normal adenoma cells. This destructive capa- 
bility is further enhanced by tumor promoters which 
stimulate the two cell activity. 
SUMMARY OF T H E  INVENTION 
The process of the present invention is directed to 
co-culturing cells to produce multicellular organoid 
tissue. The process forms and maintains 3-dimensional 
tissue of such a size as to create a multicellular organoid 
differentiation model. Combinations of cells of a wide 
variety may be cultured and maintained so that differen- 
tiation and dedifferentiation may be studied. 
DETAILED DESCRIPTION OF T H E  
INVENTION 
The co-culturing process of the present invention 
optimizes a group of culture environmental conditions, 
even as the culturing progresses, in a manner which 
greatly enhances the capability to form and maintain 
3-dimensional living tissue from either dissociated 
source cells or intact tissue resections. The 3-dimen- 
sional living tissues are formed and maintained from 
cells, which is used herein to include cells in any form, 
for example, individual cells or tissue or dissociated 
source cells or cells preattached to substrate or intact 
tissue resections. The process simultaneously minimizes 
5 
10 
15 
20 
25 
30 
35 
40 
45 
50 
55 
60 
65 
4 
the fluid shear stress, provides 3-dimensional freedom 
for spatial orientation, and extends localization of cells, 
tissues, and substrates in a similar spatial region for the 
duration of the cell culture. Transient disruptions of this 
stabilized environment are permitted and well tolerated 
for logistical purposes during initial system priming, 
sample acquisition, system maintenance, and culture 
termination. The cultured 3-dimensional tissues (and 
substrates) increase in size as the culture progresses 
necessitating appropriate adjustment of rotational rates 
with respect to vessel dimensions, external gravitational 
strength, and absolute sedimentation rate through the 
media in order to optimize these particle paths. In- 
creased external gravity field strength and increased 
tissue (and substrate) sedimentation rate induce restric- 
tions on the choice of parameters which ultimately 
limits the useful operating range of the process. These 
same factors place a lower limit on the shear stress 
obtainable even within the process operating range due 
to gravitationally induced drift of the particles through 
the culture media. Calculations and measurements place 
this minimum shear stress very nearly to that resulting 
from the particles terminal velocity (through the cul- 
ture media) for the external gravity field strength. Cen- 
trifugal and coriolus induced motion along with second- 
ary effects due to particle and fluid interactions act to 
further degrade the shear stress level as the growing 
tissue increases in size. 3-dimensionality for spatial ori- 
entation of cells, substrates, and tissues is optimized by 
selecting vessel dimensions and rotational rates which 
minimize collisions of the cultured particles with vessel 
walls or internal components. Again, increased gravity 
and particle sedimentation rate (which is proportional 
to size in all cases in our experience) cause restrictions 
to the process operating range in terms of maintaining 
3-dimensional freedom. The particular paths which 
result from rotation of cells, tissues, and substrates about 
an axis nearly perpendicular to gravity result in these 
particles, which may differ greatly in sedimentation 
rates, to remain spatially localized in similar regions for 
extended periods of time. This allows these particles 
sufficient time to interact as necessary to form multi-cel- 
lular structures and to associate with each other. The 
ability to retain this spatial approximation of particles, 
which may differ in sedimentaion properties, is de- 
graded by increasing gravity and by increasing particle 
sedimentation rate. In all three cases minimizing fluid 
shear stress, maintaining 3-dimensional freedom for 
spatial orientation, and maximizing spatial approxima- 
tion of particles with differing sedimentation properties 
we observe a degradation of performance with increas- 
ing external gravitational field strength and with in- 
creasing particle sedimentation rate. This then forms the 
basis for further enhancement of this process in a re- 
duced gravity environment. These three criteria then 
form the basis for optimization of the culture environ- 
ment. This process provides the necessary means for 
support of respiratory gas exchange, supply of nutri- 
ents, and removal of metabolic waste products. This is 
accomplished either by perfusion of media through an 
external media perfusion loop, direct injection to the 
culture media, or exchange of these molecules across a 
diffusion membrane. 
This cell and tissue culture process provides a stabi- 
lized environment into which cells or tissues may be 
introduced, suspended, assembled, grown, and main- 
tained with retention of delicate 3-dimensional struc- 
tural integrity. The fluid culture media is initially stabi- 
initial priming load of cells, tissue, and substrates. In 
most cases the initial particles with which the culture is 
primed sediment at a slow rate under 0.1 centimeter per 
second. It is therefore possible to select from a broad 
range of rotational rates (typically 5 to 120 RPM) or 10 
vessel diameters (typically 0.5 to 36 inches). The slow- 
est rotational rate is advantageous because it minimizes 
equipment wear and other logistics associated with 
handling of the culture. A vessel diameter is chosen 
which has the appropriate volume for the intended l 5  
quantity of cultured material and which will allow a 
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lized into near solid body horizontal rotation within the 11. At 48 hours the first media change usually is made 
confines of a similarly rotating vessel wall. The slowest predicated on the metabolism and the cells being 
RPM is chosen which will be sufficient to produce cultured. The growth of the culture is monitored by 
acceptable particle orbits (with respect to the 3 criteria cell counts, glucose,D02, DC02 and pH analysis. 
stated in the previous paragraph) upon addition of the 5 12. AS the culture develops from 72 hours on, daily 
adjustments are made in the rotational rate of the 
vessel dependent on the size of the cell aggregates. 
3. Cell and bead aggregates form complex cell masses 
which are oriented in a three dimensional spatial 
configuration. 
4. Growth limitation occurs as the experiment pro- 
gresses and increased rotational speed no longer suffi- 
ciently suspends the particles. In addition, increased 
rotational speeds above 35 rpm induce centrifugal 
forces which smash' the particles against the outer 
wall of the vessel destroying critical three-dimen- 
sufficient seeding density of cells, tissues, and substrates 
for the availability of these components. 
The following is an exemplary protocol for forming 
and maintaining a multicellular organoid tissue in a slow 
turning lateral vessel (STLV): 
1. An STLV is prepared by tissue culture washing and 
autoclave sterilization. 
2. The sterile, cooled vessel is placed in a Laminar Flow 
Hood and is stood upright. 
3. Average 175 micron microcarrier beads (Cytodex 3 
manufactured by Pharmacia) are hydrated and steril- 
ized before hand and diluted into a 20 mg/ml solution 
of beads in growth media. An appropriate volume of 3o 
this 20 mg/ml solution is added to the vessel to yield A three dimensional multicellular organoid mamma- 
a bead Of mg/ml in the lian cell culture was initiated in the following manner. 
volume of the vessel. The culture device. a slow turning lateral vessel 
(STLV), was prepared by washing with a tissue culture 
with growth media. The growth media is dependent 35 detergent, (micr0.x) and followed by extensive rinses 
on the type of cells being cultured in the vessel. and soaking in Milli Q ultra high purity water. The 
5. The valves are closed and the vessel is placed in a 37" device was sterilized by autoclaving and upon cooling 
C. humidified CO2incubator with 95% air 5% CO2to was rinsed for residuals with culture growth media. The 
equilibrate for 1-2 hours. The incubator surrounds vessel was in a laminar flour hood and stood 
the STLV and prevents evaporation of the n ~ d i a  40 upright. Cytodex 3 microcarrier beads (Pharmacia) 
from the STLV system. were hydrated and sterilized before hand and suspended 
6. Cell preparation required both mixed normal human in a 20 mg./ml. solution of growth media; each mg. 
colon fibroblasts and human colon tumor cells to be containing 4000 micro carriers. The vessel was filled 
trypsinized from standard culture flasks. The tWO Cell with the growth media which consisted of minimal 
types are mixed together in the correct ratio (9:1) and 45 essential medium alpha (MEM), supplemented with 
placed on ice during the wash procedure. After tryp- insulin, transferrin, selenium, ( 5  ug., 10 ug., 5 ug.), epi- 
sinization the correct cell mixture is washed 2 times dermal growth factor, sodium pyruvate, 10% fetal calf 
with phosphate buffered saline and suspended in the serum, hepes buffer 2 gramsfliter, and penicillin and 
correct growth media. This final cell mixture is held streptomycin (100 units, 100 mg./ml.). 
on ice until inoculation. 62.5 ml. of a 20 mg./ml. solution of microcarriers 
7. After equilibration and cell preparation the vessel is were added to the vessel to yield a final concentration 
inoculated with a cell number which will yield 10 of 5 mg./ml. of microcarrier in the vessel. The vessel 
cellshead of the mixed cell ratio. The total number was then filled within 10% of the final volume with 
of cells consists of the two cell types (normal human growth media. The vessel was sealed and placed in a 
colon fibroblasts and human colon tumor cells). The 55 laminar flow CO2 incubator with 95% air, 5% C02, 
cell types are mixed in a ratio that promotes coopera- 95% humidity at 37" C. to equilibrate for one hour. At 
tive effects seen in the later stages of the coculture the end of one hour, the vessel was removed from the 
process. Each mg of microcarriers contains 4O0O incubator and inoculated with 5 x lo7 cells consisting of 
beads. mixed normal human colonic fibroblasts (4 donors) and 
8. After inoculation the vessel is filled to volume with 60 HT-29KM, a partially differentiated human colon ade- 
the growth media of choice and placed in the incuba- nocarcinoma. The cells were mixed in a (9:l) ratio. 
tor. After inoculation, the vessel was closed, purged of re- 
9. Initial rotation rates of the vessel are set at 10-15 rpm. maining air bubbles and replaced in the incubator. The 
These rotation rates suspend the single cells and vessel was equipped with a 20 ml. syringe which func- 
beads to  initiate growth. 65 tioned as a compliant volume. Daily monitoring of the 
10. After 24 hours, the progress of the culture is in- growth in the vessel was accomplished by analysis of 
spected and a determination is made on the necessity DC02,  DO2, glucose, mOsm and PH. At 48 hours the 
for rotational speed. growth media was replaced for the first time and each 
EXAMPLE I 
4. The vessel is filled to all but 10% of the total volume 
50 
20 
25 
sional spatial orientation. 
15. The experiment is terminated when the factors in 
Item 13 are reached and/or when cellular metabolism 
in the STLV becomes too demanding to keep up with 
on a daily basis. 
The foregoing protocol of the STLV is only one 
bioreactor device as a specific example which may be 
used to carry out the process of the present invention. 
As specifically set forth hereinabove the process of 
coculturing may be carried out in the rotating wall 
perfused vessel (RWPV) which is described in the par- 
ent application. 
5,308,764 
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24-hours thereafter a media change was required. These rinses and soaking in Milli Q water. The device was 
changes were required to remove toxic metabolic by- assembled and then sterilized by Ethylene Oxide gas. 
products and replenish nutrient levels in the vessel. After sterilization, the vessel was placed in a laminar 
Media changes were also necessary to harvest rare flow bench and flushed with mildly acidic ultra pure 
growth products produced from the interaction of the 5 Milli Q water. At the end of a 16 hour perfusion cycle, 
multicellular organoid culture. On day 2 the rotation the vessel was drained, filled with growth media and 
rate was increased from 12 to 15 RPM. At 168 hours the allowed to stand overnight at room temperature. The 
media composition was altered to include an additional growth media consisted of minimal essential medium 
100 mg./dl. glucose as a result of increased consump- alpha (MEM), supplemented with insulin, transferrin, 
tion. At 216 hours the glucose concentration was in- 10 selenium, ( 5  ug., 10 ug., 5 ug.), epidermal growth factor, 
creased to 300 mg./dl. again due to the high rate of sodium pyruvate, 10% fetal calf serum, hepes buffer 2 
consumption. From 138 hours on the culture exhibited gramsfliter, and penicillin and streptomycin (100 units, 
cell to cell organization. At 216 hours the presence of 100 mg./ml.). The following day the vessel was drained 
well developed multicellular organoid structures were and refilled with fresh growth media and 2.5 grams of 
visible. These structures took on the appearance of I5 Cytodex 3 micro carriers. The vessel was placed in a 
circular structures or pseudocrypts. The- culture was 
terminated at 288 hours to  begin analysis of the well 
developed cellular material contained in the vessel. The 
growth media from the vessel was harvested and placed 
at - 80' C. for future analysis. The cellular material was 
removed and analyzed for structural components. 
The three dimensional multicellular organoid tissue 
was imbedded in paraffin blocks and cut in 10 and 20 
micron sections. These sections were then stained with 
mucicarmine or hematoxylin and eosin. This histologi- 
cal staining yielded the presence of microscopic cellular 
organization which was determined to  be pseudo-gland 
formation. In addition, scanning electronmicroscopy 
showed definite pseudo-crypt formation and the pres- 
ence of organized tubular structures. 
EXAMPLE 2 
A three dimensional multicellular organoid mamma- 
lian cell culture was initiated in the same manner as 
described in Example 1. 
After removal from the incubator for equilibration. 
the vessel was inoculated with 5.0X 107 cells consisting 
of mixed normal human colon fibroblasts (4 donors) and 
HT-29 a pluripotent human adenocarcinoma of the 
colon. The cell types were mixed in a ratio of (9:l). 
After inoculation, the vessel was treated as described in 
Example 1. Daily monitoring was accomplished as 
stated in Example 1. At 48-hours into the culture the 
growth media was replaced as in Example 1. The rota- 
tion rate was increased on Day 3 from 10 to 14 RPM. At 
167 hours into the culture the concentration of glucose 
in the media was raised from 100 to 200 mg./dl. This 
was a result of the increased metabolism of the culture. 
At 264 hours into the culture the growth of the tissues 
required a second increase in glucose concentration to 
300 mg./dl. The run was terminated at 408 hours. As in 
Example 1 the vessel materials were harvested and 
processed in a similar fashion. 
Upon processing of the tissues from this cell experi- 
ment, the multicellular organoid tissues expressed orga- 
nized polypoid structures. 
These polypoid structures were visible both micro- 
scopically and macroscopically with the final tissue size 
approaching 1 cm. Scanning electronmicroscopy re- 
vealed an enhanced view of complex polypoid develop- 
ment. 
EXAMPLE 3 
A three dimensional multicellular organoid mamma- 
lian cell culture was initiated in the following manner. 
The culture device, a rotating wall perfused vessel (500 
ml. Volume), was prepared by washing with a tissue 
culture detergent, (Micro-x) and followed by extensive 
C02 incubator with 95% air, 5% C02 and 9596 humid- 
ity to  equilibrate for two hours. After equilibration, the 
vessel was removed from the incubator and inoculated 
with 1 . 0 ~  106 cells consisting of mixed normal human 
20 colonic fibroblasts (4 donors) and HT-29, a pluripotent 
human adenocarcinoma of the colon. The cell types 
were mixed in a (9:l) ratio. 
After inoculation the rotating wall perfused vessel 
was placed in the laminar flow incubator. The vessel 
25 was equipped with a 20 ml. syringe which functioned as 
a compliant volume. The initial wall, vane, and spin 
filter rotations were set at 18-20 RpM. The perfusion 
pump was left off for the first 9 hours of the run. At 9 
hours into the experiment the pump rate was set at 2.5 
30 ml./min. Daily monitoring of the growth in the vessel 
was accomplished by analysis of DCO 2. DO2, glucose, 
mOsm and pH. At 48 hours 600 ml. of fresh growth 
media was perfused into the vessel. This procedure 
removed any dead or non-attached cells. At 96-hours 
35 the vessel was perfused with 600 ml. of fresh growth 
media to remove toxic metabolic by-products and re- 
plenish nutrient levels. At 120-hours the in-line filter 
became clogged with debris from the rotating seals and 
the emergency by-pass valve was opened. In addition, 
40 600 ml. of fresh media was also perfused at this time 
point. At 167 hours into the experiment 600 ml. of 200 
mg./dl. glucose growth media was perfused into the 
vessel. 
At 192 hours into the experiment the perfusion pump 
45 rate was increased from 2.5 to 4.0 ml./min. and 600 ml. 
of fresh media was perfused into the vessel. The pump 
rate was increased to 6 ml./min. at 216 hours and 600 
ml. of fresh media was perfused into the system. At 264 
hours the pump rate was increased to 9 ml./min. and 
50 fresh media (600 ml.) was added to the system. At this 
point the glucose concentration had to be increased to 
300 mg./dl. At 288 hours the pump rate was increased 
to 10 ml./min. and 600 ml. of 300 mg./dl. glucose was 
perfused. The pump rate was increased to 11.5 ml./min. 
55 at 314 hours and 20 ml. of 50 mg./ml. glucose was 
added to the system. At 360 hours the pump rate was 
increased to 13 ml./min. and 600 ml. of 300 mg./dl. 
glucose growth media was perfused. 600 ml. of 300 
mg./dl. glucose media was perfused at 384 hours. The 
60 experiment was terminated at 408 hours. From 167 
hours into the experiment through to the end the cul- 
ture exhibited multicellular, structural development. 
Polypoid formation was evident at first by light micros- 
copy and later macroscopically. The growth media was 
65 harvested from the vessel and placed at -80" C. for 
later analysis. The multicellular tissue material was 
removed from the vessel and divided into samples for 
analysis. Analysis of the three dimensional organoid 
5,308,764 
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tissue which had been imbedded in paraffin and sec- 
tioned. revealed the presence of complex polypoid 
structures and specific areas of cellular differentiation. 
These determinations were made by means of mucicar- 
mine and hematoxylin and eosin stains. 
7. The living mammalian tissue of claim 1 wherein the 
vessel is located in unit gravity. 
8. The living mammalian tissue of claim 1 wherein the 
method of sustaining said media is by perfusion. 
9. The living mammalian tissue of claim 1 wherein the 
cell attachment substrates are microcarrier beads. 
10. The living mammalian tissue of claim 7 wherein 
the vessel is rotated within the range of 5 and 25 RPM, 
and the RPM is increased as the density of the assembly 
11. A multi-cellular, three-dimensional, living mam- 
malian tissue of at least two distinct originating cell 
types having complex polypoid structures and specific 
areas of cellular differentiation produced in vitro by: 
5 
We claim: 
1. A multi-cellular, three-dimensional, differentiated, 
living mammalian tissue of at least two distinct originat- 
ing cell types produced in vitro by: 
providing a bioreactor having a culture chamber 10 increases. 
rotatable about an approximately horizontal longi- 
tudinal axis, means to controllably rotate said cul- 
ture chamber, means to oxygenate said culture 
chamber and means to remove metabolic waste 
products therefrom; 15 
filling said culture chamber completely with a fluid 
nutrient media, cell attachment substrates, and indi- 
vidually dispersed mammalian cells of at least two 
distinct types to  establish a culturing environment; 
rotating said culture chamber about its longitudinal 20 
axis, oxygenating the culturing environment within 
said culture chamber and removing metabolic 
waste products therefrom; 
controlling the rotating of said culture chamber such 
that the culturing environment except during tran- 25 
sient periods has the following simultaneous prop- 
erties: 
a. collocation of cells and attachment substrates 
with similar or differing sedimentation proper- 
ties in a similar spatial region, 
b. freedom for three-dimensional spatial orientation 
of tissues formed by the culturing of the cells. 
and 
c. low shear and essentially no relative motion of 
said culturing environment with respect to the 35 
walls of the culture chamber; and 
30 
determining the trajectory of the tissues, in response 
to said determining step: increasing the speed of 
rotation of the culture chamber if the tissues fall 
excessively inward and downward on the down- 40 
ward side of the rotational cycle and excessively 
outward and insufficiently upward on the ongoing 
side of the rotational cycle to prevent wall impact; 
or decreasing the speed of rotation of the culture 
chamber in response to excessive accumulation of 45 
the tissues near the outer wall of the culture cham- 
ber so as not restrict three-dimensional assembly, 
and as the size of the tissues increase beyond the 
capability to fully satisfy the above three properties 
by further increase of the speed of rotation, select- 50 
ing a rotational rate to visually obtain minimal 
collision frequency and intensity. 
2. The multi-cellular, three-dimensional living mam- 
malian tissue specified in claim 1 in which one cell type 
is stromal cells and the other cell type is epithelial cells. 55 
3. The multi-cellular, three-dimensional living mam- 
malian tissue specified in claim 1 in which one cell type 
is fibroblasts and the other cell type is pluripotent 
providing a bioreactor having a culture chamber 
rotatable about an approximately horizontal longi- 
tudinal axis, means to controllably rotate said CUI- 
ture chamber, means to oxygenate said culture 
chamber and means to remove metabolic waste 
products therefrom; 
filling said culture chamber completely with a fluid 
nutrient media, cell attachment substrates, and indi- 
vidually dispersed mammalian cells of at least two 
distinct types to  establish a culturing environment; 
rotating said culture chamber about its longitudinal 
axis, oxygenating the culturing environment within 
said culture chamber and removing metabolic 
waste products therefrom; 
controlling the rotation of said culture chamber such 
that the culturing environment except during tran- 
sient periods has the following simultaneous prop- 
erties: 
a. collocation of cells and attachment substrates 
with similar or differing sedimentation proper- 
ties in a similar spatial region, 
b. freedom for three-dimensional spatial orientation 
of tissues formed by the culturing of the cells, 
and 
c. low shear and essentially no relative motion of 
said culturing environment with respect to the 
walls of the culture chamber; and 
determining the trajectory of the tissues, in response 
to said determining step: increasing the speed of 
rotation of the culture chamber if the tissues fall 
excessively inward and downward on the down- 
ward side of the rotational cycle and excessively 
outward and insufficiently upward on the ongoing 
side of the rotational cycle to prevent wall impact; 
or decreasing the speed of rotation of the culture 
chamber in response to excessive accumulation of 
the tissues near the outer wall of the culture cham- 
ber so as not restrict three-dimensional assembly, 
and as the size of the tissues increase beyond the 
capability to fully satisfy the above three properties 
by further increase of the speed of rotation, select- 
ing a rotational rate to visually obtain minimal 
collision frequency and intensity. 
12. The multi-cellular, three-dimensional living mam- 
I
human adenocarcinoma. 
malian tissue specified in claim 1 in which one cell type 
is normal human colon fibroblasts and the other cell 
type is human colon tumor cells. 
5. The multi-cellular, three-dimensional living mam- 
malian tissue specified in claim 4 in which the fibro- 65 
blasts and tumor cells are at a 9:l ratio. 
6. The living mammalian tissue of claim 1 wherein the 
vessel is located in microgravity. 
malian tissue specified in claim 11 in which the tissue 
4. The multi-cellular, three-dimensional living mam- 60 resides on a matrix formed of molecularly permeable 
microcarrier beads. 
13. The multi-cellular, three-dimensional living mam- 
malian tissue specified in claim 12 which includes pseu- 
do-crypt formations and organized tubular structures. 
14. The multi-cellular, three-dimensional living mam- 
malian tissue specified in claim 13 in which one cell type 
is normal human colon fibroblasts and the other cell 
type is human colon tumor cells. 
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15. The multi-cellular, three-dimensional living mam- c. low shear and essentially no relative motion of 
malian tissue specified in claim 14 in which the fibro- said culturing environment with respect to the 
walls of the culture chamber; and blasts and tumor cells are at a 9:l ratio. 
determining the trajectory of the tissues, in response 16. The multi-cellular, three-dimensional living mam- to said determining step: increasing the speed of 
rotation of the culture chamber if the tissues fall malian tissue specified in claim 12 which includes inter- 
cellular substances such as extracellular matrices and excessively inward and downward on the down- 
basement membranes. ward side of the rotational cycle and excessively 
17. A multi-cellular, three-dimensional, living mam- outward and insufficiently upward on the ongoing 
malian tissue of at least two distinct originating cell 10 side of the rotational cycle to prevent wall impact; 
types residing on a matrix formed of molecularly per- or decreasing the speed of rotation of the culture 
chamber in response to excessive accumulation of meable microcarrier beads produced in vitro by: 
the tissues near the outer wall of the culture cham- providing a bioreactor having a culture chamber ber so as not restrict three-dimensional assembly, 
tudinal axis, means to controllably rotate said cul- capability to fully satisfy the above three properties 
ture chamber, means to oxygenate said culture by further increase of the speed of rotation, select- 
chamber and means to remove metabolic waste ing a rotational rate to visually obtain minimal 
products therefrom; collision frequency and intensity. 
filling =id culture chamber completely with a fluid 20 18. The multi-cellular, three-dimensional living mam- 
nutrient media, cell attachment substrates, and indi- malian tissues specified in claim 17 in which one cell 
vidually dispersed mammalian cells of at least type is stromal cells and the other cell type is epithelial 
cells. distinct types to establish a culturing environment; 19. The multi-cellular, three-dimensional living mam- 
in claim which includes intra- 
axis, oxygenating the culturing environment within cellular substances such as extracellular matrices and 
said culture chamber and removing metabolic basement membranes, 
waste products therefrom; 20. The multi-cellular. three-dimensional living mam- 
controlling the rotation of said culture chamber such malian tissue specified in claim 18 in which the tissue 
that the culturing environment except during tran- 30 has complex polypoid structures and specific areas of 
sient periods has the following simultaneous prop- cellular differentiation. 
erties: 21. The multi-cellular, three-dimensional living mam- 
malian tissue specified in claim 18 in which one cell type a. collocation of cells and attachment substrates is normal human colon fibroblasts and the other cell 
22. The multi-cellular, three-dimensional living mam- 
malian tissue specified in claim 21 in which the fibro- 
blasts and tumor cells are at a 9:1 ratio. 
5 
about an longi- 15 and as the size of the tissues increase beyond the 
rotating said culture chamber about its longitudinal 25 malian tissue 
with similar or differing sedimentation proper- 3s type is human colon 
ties in a similar spatial region, 
b. freedom for three-dimensional spatial orientation 
of tissues formed by the culturing of the cells, 
and 
cells, 
* * * * *  
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